← Evidence map

TrialActa neuropsychiatrica2024

A randomised study and an extension study of brexpiprazole in patients with borderline personality disorder.

Brian Rothman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 39558901